trending Market Intelligence /marketintelligence/en/news-insights/trending/td9jy9sZeJpyWR2ASXrpcw2 content esgSubNav
In This List

Bellicum Pharmaceuticals appoints chief business officer

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet


Bellicum Pharmaceuticals appoints chief business officer

Gregory Naeve will become Bellicum Pharmaceuticals Inc.'s chief business officer Aug. 21.

Naeve was previously immuno-oncology and cell therapy lead for Pfizer Inc.'s external research and development unit.